Meeting
2016 ASCO Annual Meeting
Biologic heterogeneity of KRAS-mutated lung adenocarcinomas (K-ADC).
Authors
Tiffany Huynh
Massachusetts General Hospital, Boston, MA
Tiffany Huynh , Justin F. Gainor , Valentina Nardi , Mari Mino-Kenudson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 8532)
DOI
10.1200/JCO.2016.34.15_suppl.8532
Abstract #
8532
Poster Bd #
160
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Clinicopathological and molecular parameters of lung adenocarcinomas (ADC) associated with programmed cell death ligand 1 (PD-L1) protein expression.
First Author: Tiffany Huynh
Poster
2021 ASCO Annual Meeting
Differential immune-related microenvironment determines PD-1/PD-L1 blockade efficacy in advanced non-small cell lung cancer patients.
First Author: Masayuki Shirasawa
Poster
2017 ASCO Annual Meeting
Differential expression of immune inhibitory markers in association with HLA class I and the immune microenvironment in resected lung adenocarcinomas.
First Author: Mingjuan Lisa Zhang
Poster
2014 ASCO Annual Meeting
PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
First Author: Sascha Ansen